News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
10-Jan-2013 - Pepscan Therapeutics announced a multi-target research agreement with an undisclosed US-based antibody discovery company.Under the agreement Pepscan using its CLIPS platform and other protein mimicry technologies will work with the partner in the discovery of novel antibodies. Under the terms of ...
10-Feb-2012 - Pepscan Therapeutics B.V. announced that it has achieved two milestones in the Research Collaboration with Janssen R&D Ireland, formerly Tibotec Pharmaceuticals, and received undisclosed payments. In the collaboration, Pepscan has discovered novel peptides with potential therapeutic utility ...
11-May-2011 - Phylogica Ltd and Pepscan Therapeutics announced that they have entered a Research Collaboration and Option Agreement to evaluate the combination of their complementary peptide technologies for drug discovery. Under the terms of the agreement, Pepscan using its CLIPS technology will work with ...
06-Apr-2011 - Pepscan Therapeutics announced the appointment of Michiel Lodder as Chief Business Officer. Dr. Lodder joins Pepscan from Octoplus, where he held the position of Senior Manager Business Development, responsible for licensing, partnering, and alliance management activities.Michiel Lodder holds a ...
14-Mar-2011 - Pepscan Therapeutics announced that it has signed a Research and License Agreement with Crucell Holland B.V.. In the research collaboration, Crucell will make use of Pepscan’s proprietary technology and know-how in Crucell’s program for developing undisclosed novel vaccines to combat infectious ...
06-Jan-2011 - Mercator Therapeutics and Pepscan Therapeutics announced a multi-program research collaboration. The companies will collaborate to optimize Mercator’s ‘Homing Peptides’ using Pepscan’s proprietary CLIPS technology. Mercator’s Homing Peptides are discovered through a unique in vivo screening ...
30-Sep-2010 - Pepscan Therapeutics announced the establishment of a Scientific Advisory Board (SAB). The SAB will guide the company in the further development and application of its core protein mimicking technology for the creation of novel therapeutic peptide drugs and monoclonal antibodies. The ...
15-Sep-2010 - Pepscan Therapeutics announced that it has signed a Research and License Agreement with Tibotec Pharmaceuticals. Under the agreement Pepscan using its CLIPS technology will work with Tibotec to develop novel therapeutic peptides against an undisclosed target. Under the terms of the agreement, ...
05-Mar-2008 - Genmab A/S and Pepscan announced the start of a research collaboration aimed at identifying fully human monoclonal antibodies against intractable disease targets. Intractable targets include those that are difficult to address using commonly available technologies but are highly desirable for ...
© 1997-2024 LUMITOS AG, All rights reserved